Under den 24 uger dobbeltblinde fase modtog patienterne enten 5 mg/ kg infliximab eller placebo i ugerne 0, 2, 6, 14 og 22 (100 patienter i hver gruppe).
During the 24-week double-blind phase, patients received either 5 mg/ kg infliximab or placebo at weeks 0, 2, 6, 14, and 22 (100 patients